See also this year's filing and all EDGAR filings for this company.
PDF Report 0000855654_2012_Immunogen_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000855654, Immunogen Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 201,525,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 13,409,000 |
| 3 | remainder_Assets | 2,707,000 |
| 4 | LiabilitiesCurrent | 14,566,000 |
| 5 | LiabilitiesNoncurrent | 3,978,000 |
| 6 | remainder_Liabilities | 59,128,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,040,000 |
| 9 | ResearchAndDevelopmentExpense | 63,453,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 19,305,000 |
| 12 | remainder_NetIncome | 1,914,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 217,641,000 |
| 1 | Liabilities | 77,672,000 |
| 2 | Expenses | 79,493,000 |
| 3 | Revenues | 19,305,000 |
| 4 | StockholdersEquity | 139,969,000 |
| 5 | NetIncome | -58,274,000 |
| 6 | ComprehensiveNetIncome | -58,274,000 |
| 7 | BaseVar | 198,012,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.67 |
| 9 | EconomicCapitalRatio | 2.80 |
Edgar->Model Mapping
Feature Distribution
